✦ LIBER ✦

Everolimus in Combination with Exemestane for Postmenopausal Women with Advanced Breast Cancer Who Are Refractory to Letrozole or Anastrozole: Results of the BOLERO-2 Phase III Trial

✍ Scribed by J. Baselqa; M. Campone; T. Sahmoud; M. Piccart; H. Burris; H. Rugo; S. Noguchi; M. Gnant; P. Mukhopadhyay; G. Hortobagyi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BOLERO-2: Everolimus in combination with

✍ Mario Campone; Martine Piccart; Kathleen I. Pritchard; Cindy Xu; Michael Gnant; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

253 Everolimus (EVE) for Postmenopausal

✍ H. Rugo; K.I. Pritchard; M. Gnant; S. Noguchi; M. Piccart; G.N. Hortobagyi; H.A. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

3LBA Everolimus Added to Exemestane Redu

✍ M. Gnant; G.N. Hortobagyi; H. Rugo; H.A. Burris; S. Noguchi; K.I. Pritchard; J. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 45 KB